Clinical trial
Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides
NCT00187733 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides
- Lead sponsor
- University of California, San Francisco
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- February 29, 2008
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carnitine transporter deficiency